H43.21
Crystalline deposits in vitreous body, right eye
Clinical Classification Guidelines
Medical Intelligence & Overview
Crystalline deposits in the vitreous body of the eye, classified under ICD-10 code H43.21, refer to small, bright particles that appear within the gel-like substance occupying the main part of the eye's interior. The vitreous body is responsible for maintaining the eye's shape and enabling light transmission to the retina. When deposits form in this area, they can affect vision and may be indicative of underlying health conditions or age-related changes. This guide provides a comprehensive overview aimed at informing patients about this condition, including possible causes, symptoms, diagnostic procedures, and general approaches to management.
Causes & Symptoms
Clinical Causes: Age-related changes leading to the degeneration of vitreous fibers Degeneration of metabolic components within the vitreous gel Floaters due to tiny condensed remnants of the vitreous gel Intraocular hemorrhage or blood breakdown products Myopia (nearsightedness) associated with increased vitreous changes Previous eye trauma or eye surgery Certain systemic conditions such as diabetes or inflammatory diseases Presence of crystalline deposits secondary to mineral or protein precipitation Rarely, deposits may be related to systemic diseases like gout or calcification disorders
Key Symptoms: Perception of floaters or small moving spots in vision Strange or shimmering visual disturbances Occasional flashes of light No pain, redness, or significant visual loss in many cases In some instances, deposits may interfere with clarity of vision if prominent
Diagnostic & Treatment
Diagnosis Path: The diagnosis involves a comprehensive eye examination by an ophthalmologist, which includes: - Visual acuity testing to assess clarity of vision - Slit-lamp examination to observe the vitreous and retinal structures - Fundus examination, potentially using ophthalmoscopy, to visualize the deposits - Visual phenomena or floaters report and their impact on daily activities - In some cases, ocular imaging techniques such as ultrasound or optical coherence tomography (OCT) may be used to better assess vitreous changes and detect associated retinal issues
Treatment Protocols: Management of crystalline deposits in the vitreous body primarily depends on the severity and impact on vision: - Observation and reassurance for benign floaters that do not significantly impair vision - Addressing any underlying systemic or ocular conditions that may contribute to deposit formation - In cases where floaters are severe or vision obstructed, options such as vitreous surgery (vitrectomy) may be considered - Laser therapy, in some instances, may help reduce the appearance of floaters but carries potential risks - Ongoing monitoring is essential to identify any developments such as retinal tears or detachment - Lifestyle modifications, including protection from eye trauma and control of systemic health conditions, may help minimize progression
Clinical Advice & FAQs
Billing Guidance
Is H43.21 a billable ICD-10 code?
Yes, H43.21 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report H43.21?
Clinical documentation must specify the nature of Crystalline deposits in vitreous body, right eye and any associated comorbidities for accurate reporting.
Cite this Clinical Reference